Record Revenue Growth
Sensus Healthcare reported a 71% increase in annual revenue, reaching $41.8 million compared to $24.4 million in 2023.
Increase in SRT-100 System Sales
The company delivered a record 115 SRT-100 systems in 2024, a 74% increase over the previous year, with 39 systems delivered in the fourth quarter alone.
Strong Profitability
Sensus achieved its fifth consecutive quarter of profitability with a net income of $1.4 million, ending the year with $22.1 million in cash and no debt.
Expansion of Fair Deal Agreement Program
The Fair Deal Agreement program gained significant traction, particularly among large dermatology groups, creating recurring revenue streams.
International Market Penetration
Five systems were shipped to international customers in the fourth quarter, contributing to a total of ten international shipments for the year.
Entry into Veterinary Market
Sensus sold its first SRT system to a veterinary clinic, indicating potential for expansion into the animal health sector.